Tibulizumab (Anti-BAFF & IL-17)
Product Specifications
CAS Number
1849636-24-3
Synonyms
LY3090106
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Tibulizumab (LY3090106) is a tetravalent bispecific antibody which potently inhibits both B cell activating factor (BAFF), also known as CD257 and interleukin-17A (IL-17) . It is used for the treatment of autoimmune diseases. MW: 201.44 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880218-100 1x 100 µL
CD100 (Semaphorin-4D) (A8), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680352-500 1x 500 µL
CD31 / PECAM-1 (158-2B3), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741099-500 1x 500 µL
CD31 / PECAM-1 (C31.3 + C31.7 + C31.10), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742951-500 1x 500 µL
CDX2 (GI Epithelial Marker) (CDX2/2951R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400640-100 1x 100 µL
CD34 (QBEnd/10), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details